If a patient has a family history of MS, would you treat the patient with a TNF Blocker or switch to something else?
Featuring Benjamin Lockshin, MD | EVP of Strategic InitiativesDirector of the Clinical Trials CenterAssistant ProfessorUS Dermatology PartnersGeorgetown UniversityRockville, MD | Published April 15, 2022
Related Media
Powered by Polaris TM